Author(s):
In recognition of February as National Cancer Prevention Month, ACCC shares strategies to reduce the risk of cancer, including prioritizing genetic testing and early conversations with a health care provider.
February is National Cancer Prevention Month, a time to raise awareness about strategies to reduce the risk of cancer and empower people to make more informed decisions about their health. One of the most significant—and sometimes overlooked—ways to prevent cancer is by understanding one’s genetic risk. Genetic testing, paired with open and early conversations with a health care provider, can play a crucial role in identifying potential risks before they become critical.
Family history is one of the most influential factors in determining an individual’s risk for certain types of cancer. Several cancers, including breast, ovarian, uterine, and colorectal cancer, have genetic links that are passed down through families. In addition, recent advancements in the genetics of prostate cancer have shown the presence of germline mutations associated with a higher risk of developing prostate cancer. ACCC has launched an educational initiative to identify practice gaps related to germline and somatic testing for hereditary mutations in metastatic prostate cancer.
Genetic testing can be a game changer in identifying individuals at a higher risk of developing cancer. Genetic tests detect mutations in specific genes that can predispose people to certain types of cancer, allowing them to make early, proactive decisions about their health, such as:
In many cases, genetic testing is recommended for individuals with a strong family history of cancer. However, as genetic testing becomes more widely available and accessible, even those with no family history may consider testing for reassurance or as part of a wellness strategy.
Open and honest communication with a health care provider is essential in assessing one’s risk of cancer. For individuals who have a family history of cancer, it is important to bring this information up during routine visits. Ideally, this conversation should take place early on—before any signs or symptoms appear.
Engaging in this dialogue early on can reduce patients’ fear and anxiety by determining a plan of action before the threat of a cancer diagnosis looms. The proactive decision to order genetic testing based on family history and the creation of a prevention plan greatly improves patient outcomes as well.
Genetic counselors specialize in interpreting genetic test results and discussing the implications with patients, making them essential members of the cancer care team. Genetic counselors can help patients understand their cancer diagnosis, interpret what their results mean, make informed treatment decisions, and navigate the financial cost of testing. If necessary, they may also help facilitate genetic testing for other at-risk family members and refer patients to financial advocates or patient assistance resources.
Cancer Prevention Month is a reminder that taking charge of your health can significantly lower your cancer risk. By understanding your genetic predispositions and having proactive conversations with your health care provider, you are setting the foundation for a healthier future. Early detection, prevention, and personalized care can make all the difference in the fight against cancer.
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
